6515--FY25 IDIQ GENDX Reagent

Closed Special Notice Posted

Solicitation number
36C26325Q0013
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

This Special Notice is published by the Department of Veterans Affairs, Veterans Integrated Service Network 23 Contracting Office. It announces the agency's intent to award a sole source firm fixed price contract to GENDX PRODUCTS INC for the procurement of Next Generation Sequencing (NGS) reagent kits to support the Histocompatibility and Immunogenetics Laboratory at the Iowa City VA Health Care System.

The purpose of this Special Notice is to provide information about the proposed contract action and to solicit capability statements from interested vendors. The required NGS reagent kits are used to perform identification of human leukocyte antigen alleles. The contract will be awarded under the authority of 41 U.S.C. 3304(a)(1), as GENDX PRODUCTS INC's kits have been validated as compatible with the VA's current in-house equipment. The response deadline is September 25, 2024 at 8:00 AM Central Time. Interested vendors may submit capability statements providing documentation that they can provide the required services as an authorized reseller, dealer, or third party. The North American Industry Classification System (NAICS) code is 325411 (Medicinal and Botanical Manufacturing) and the Product Service Code (PSC) is 6515 (Medical and Surgical Instruments, Equipment, and Supplies).

Notice text

This is a Notice of Intent published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This Notice of Intent is for a proposed award of a sole source firm fixed price contract to the following contractor in support of Histocompatibility and Immunogenetics Laboratory in support of Iowa City VA Health Care System, 601 Highway 6 West, Iowa City, IA 52246-2209:

GENDX PRODUCTS INC

SAM UEI: JFZKARM2NL52

5521 N Cumberland AVE

STE 1116

Chicago, Illinois

60656-1479, United States

This is done under authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1: Only one source and no other supplies or services will satisfy agency requirements.

This is not a request for competitive quotes.

Market research revealed that GENDX PRODUCTS INC GenDx NGS Kits have been validated to be compatible with current inhouse equipment that is currently being utilized by Iowa City VA Health Care System.

Required on contract are NGS reagent kits used to perform identification of human leukocyte antigen alleles through amplification of A, B, C, DPA1, DPB1, DQA1, DQB1, DRB1, DRB3/4/5. The GENDX PRODUCTS INC GenDx NGS Kits are found to be compatible with the current inhouse equipment used in the HLA lab. After selection of the appropriate assays and reagents the testing performed was validated and utilized for transplant genotyping and aids in selection of organs. To switch to a new vendor of reagents requires a long validation process, approval by the ASHI Accreditation Review Board to change the protocol and ensure the validation was successful. Due to the complexity of this process the is only able to utilize GenDx NGS Kits.

The North American Industry Classification System (NAICS) code for this service is 325411 (Medicinal and Botanical Manufacturing) and the Product Service Code (PSC) is 6515 (Medical and Surgical Instruments, Equipment, and Supplies).

While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy the requirement, including documentation that such contractor could provide this service as an authorized reseller, authorized dealer or third party.

All responsible sources may submit a capability statement, which shall be considered by the agency by e-mailing such statement and supporting documentation to Christi Melendez, Contracting Specialist, at Christi.Melendez@va.gov. No phone calls please. Please indicate Response to GENDX Reagents in subject line of e-mail.

Such documentation will be reviewed solely for the purpose of determining whether or not to conduct the procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government under authorities cited above.

Files

File Type Posted
36C26325Q0013.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
NOI - DNA Sequencing of Bone Marrow Failure Syndro NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
Q301--NEW – STX Specialized Molecular Residual Disease Testing NAICS 621511 Veterans Integrated Service Network 17 No set-aside
6550--Cepheid GeneXpert Testing Supplies Beckley Vamc Clarksburg Vamc Vamhcs Washington Vamc · NAICS 325413 Veterans Integrated Service Network 5 No set-aside
6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ Department of Veterans Affairs VA North Atlantic Health Network HSA 1.3 Various Locations, United States · NAICS 325413 Veterans Integrated Service Network 5 No set-aside
Reagents and consumables for Roche immunostainers Bethesda, Maryland 20892, United States · NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity